Taichung Tzu Chi Hospital clinical trial pipeline

2 trials changed in the last 30 days: 1 stopped, 1 with a notable change, 0 with minor changes only.

1. Stopped

   Antrodia Cinnamomea on the Hepatoma Patients After Transcatheter…Antrodia Cinnamomea on the Hepatoma Patients After Transcatheter Hepatic Artery Chemoembolization

   Trial terminated

   Also in this update: Primary completion date changed from estimate of Dec 31, 2025 to Oct 2, 2026; Final enrollment: 23 participants (planned 60)

   Taichung Tzu Chi Hospital·Not applicable· NCT07178093· Registry history of NCT07178093 on ClinicalTrials.gov (opens the registry)

   Oct 6, 2026

2. Notable

   Danggui Shaoyao San and Cuscuta Chinensis · Primary Dysmenorrhea

   Trial status changed: Unknown → Terminated

   Also in this update: Primary completion date changed from estimate of Jun 30, 2026 to Sep 12, 2026; Start date changed from estimate of Dec 1, 2024 to Feb 14, 2025

   Taichung Tzu Chi Hospital·Not applicable· NCT06730282· Registry history of NCT06730282 on ClinicalTrials.gov (opens the registry)

   Oct 19, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.